The document discusses the bioPmed cluster initiative in Italy's Piedmont region, which brings together companies, universities, and research centers working in life sciences and medical technologies. The initiative takes a strategic approach to personalized medicine focusing on converging multiple technologies. This includes areas like biotech, medical devices, ICT, and others. The goal is to develop innovative solutions for healthcare by combining diverse technological expertise. BioPmed has over 80 core members and works internationally with other clusters through partnerships and shared projects.

1. / 1Bioindustry Park 2013– All Rights Reserved

2. / 2Bioindustry Park 2013– All Rights Reserved
Alberto Baldi
baldi@bioindustrypark.it
Munich, May 28th, 2013
bioPmed, a step beyond personalised
medicine

3. / 3Bioindustry Park 2013– All Rights Reserved
 Piemonte cluster and Bioindustry Park
Silvano Fumero
 Key trends
 bioPmed cluster initiative
 bioPmed strategic approach
 Concept scale-up
 Take away messages and offer
CONTENTS

4. / 4Bioindustry Park 2013– All Rights Reserved
Torino
Verbania
Biella Novara
Vercelli
Alessandria
Cuneo
Asti
 4.4 million inhabitants
 € 123.4 billion GDP
 € 38.5 billion export
 467,500 companies
 € 2.2 billion R&D investments
 1,000 R&D contracts
 220 R&D centers, 380 Labs
 6 Science & Technology Parks
 4 Universities
 Strong relationships with
other European Regions
1st region in Italy for:
 Private R&D investment
Hi-tech patents
ITALY: PIEMONTE REGION

5. / 5Bioindustry Park 2013– All Rights Reserved
Science Park focused on life sciences, created with the support of
Regione Piemonte in the EU programs framework (beginning 90’s) -
Operational since 1998.
It hosts more than 30 organizations
Managing company of the Innovation Cluster bioPmed
Member of national and international networks
 22.000 sqm labs, office spaces
 R&D shared facilities
 R&D scientific services (Able
Biosciences initiatives)
 1 incubator
 Consultancy in biomanagement
 Conference centre
www.bioindustrypark.eu
Offer
BIOINDUSTRY PARK SILVANO FUMERO

6. / 6Bioindustry Park 2013– All Rights Reserved
KEY TRENDS
• Health care is a priority for all actors of the value chain
– Societal needs
– Cost pressure
– Lead markets (e.g. Ageing, metabolic diseases, cancer, CNS, etc)
– Political priority (Horizon 2020)
• The paradigm for health care is changing
– From a “pill for all” to a personalised approach
– From an acute problem to a managed problem
– From local development to global value creation networks
– From a “mono-technoligical” approach to a converging
technologies approach (Es. diagnostic + therapies + devices
altogether)
• The health care sector has now a global, multi-
technological and trans-market dimension, touching also
different “traditional” sectors, from agro-food to ICT.

7. / 7Bioindustry Park 2013– All Rights Reserved
A EU “world class cluster” dedicated to bio and medical technologies –
created in 2009
A core founder of the ALISEI (Advanced LIfe SciEnces in Italy) national
cluster that involves 13 different regional actors
80+
CORE
MEMBERS
370+
ENLARGE
COMMUNITY
National &
International Hubs
The bioPmed
Community
A shared smart approach for
innovation:
converging technologies
BIOPMED CLUSTER INITIATIVE
“Overlapping different
technological knowledge
to reach innovative
solutions to ensure a
better future”
Synergies with local
clusters (ICT, New
materials,
textiles...), with EP
and non EP clusters
∼200 health care
132 R&D centers
3924 scientists
Companies, Universities,
R&D centers, foundations

8. / 8Bioindustry Park 2013– All Rights Reserved
Project
building
Working
groups
Community
building
Shared
access to
infrastructures
(material /
immaterial)
R&D
Projects
Added
value shared
services
International networking International clusters
Governance – Labeling
Regional
financing
Events organisation and participation, information,
opportunities and support to single companies, universities
and agencies in sectorial internationalisation
Council of European
Bioregions
International projects
International agreements
Soft landing agreements
SMEs INTERNATIONALISATION AND
THE CLUSTER ENVIRONMENT: BIOPMED APPROACH

9. / 9Bioindustry Park 2013– All Rights Reserved
bioPMed obtained the “Bronze Label”
from the European Secretariat for Cluster
Analysis”
bioPmed ranked 1st in a national
performance evaluation of clusters and
science parks
Source: “Dai distretti industriali ai poli di innovazione.
L'Italia nel Mediterraneo, M. Ferarra, R. Mavilia EGEA,
2012”
Companies contacted and involved 330
Scientist contacted and involved 3500
Organizations formally and
contractually linked
82
Total output project building
activities
143
Technical work-shops organized 34
Companies involved in
internationalisation and international
activities
147
Advanced services financed 15
Feasibility studies and R&D
projects financed
29
EU funded project ongoing and
presented
10
% of members involved in projects
(cumulative)
100%
Overall value of initiatives linked to
cluster activities
20.860.231
Involvement in institutional advisory
board external to the region
4
BIOPMED: PERFORMANCES

10. / 10Bioindustry Park 2013– All Rights Reserved
Genomics,
Biochemistry,
Molecular
&cellularbiology
Diagnostic
&Theranostics
Electronical,medical
&laboratory
equipment
Medicalbiomaterials
Medicaltechnology
&Biomedical
engineering
Functionalfood
Microbiological
consortia
Computersciences
Disease Prevention ROTARIC ATHIMAG
SAFE TAN
SUN TAN
PREVI
IaRO
ROTARIC
Nutratec
MicoDiaBreas
t
ARAS
BACOSTE
Prothesis, biomedical
Devices/instrumenta
tion
& drug delivery
BIOBONE
CARDIOMITRAL
SWAP
SiNplant
Self exp. DES
TINET; I.B.G.
IPEEI
BONEJECT
KEME
PIEDMONT
BIOMAG
ANTIBACOSS
Dense-gas CRYO
CRYOPHARMA
NANOSTENT
FIDIS
BIOMICROFAB
DESTINI
WILOP; JIGTO
FACE; ORECO
BIOMAG
NeuroVirtual3D
Nuvola3D
RICCAmente
Regenerative
Medicine MOSQUITO
HYPERSPECTRA
STELLA
BICONerve
TINET; I.B.G.
QUANTADIPO
BONEJECT
PIEDMONT
ANTIBACOSS
PLA scaffolds
NanoStem
B.B.S.
FACE
WEB BI
Pharmaceutical
TAB2
NOVADEP
TLR7A
ERP
NATIMAB
ATHEROVAX
PSSEIK
Personalized
Molecular Medicine MOSQUITO
GNRs
Pred_HEALTH
FaPre
P-MOSP
Diagnostic
EPIgenetic screening
NuGeSa
FAST
Beta-agonist detection
DMS; Bioprotech
ATHIMAG
HYPERSPECTRA; STELLA
LOCHTECH
MicroDiBi
PROMOTECO
BANP.
TrCD; Idata
E_LAB; FAST
P-MOSP
Veterinary
FLUOMAG
CANESTRO
Specialisation fields have
been derived from company
based projects

11. / 11Bioindustry Park 2013– All Rights Reserved
EAPB
Biobay,
Scientific
Park
FABA
Federation of
Asian Biotech
Associations
CBS
FR: Lyonbiopole; ADEBAG; Eurobiomed; Genopole;
I-Care
DE: BioM; Technologiepark Heidelberg, bioTop
PL: Wrocław Center for S&T in Medicine
ES: BioCAT; Parque Tecnologico di Vizkaia
IT: Toscana Life Sciences
CH: BioAlps ; DK: MVA
UK: One Nucleus; SWE:
Stockolm Science City
Technology
Centre of New
Jersey
Israel
BioNegev cluster;
RAD biomed
BioCulture
FIPASE
eLSi
BIOPMED: INTERNATIONAL NETWORK AND PROJECTS

12. / 12Bioindustry Park 2013– All Rights Reserved
The “traditional approach”
(One problem, one technology, one solution)
The “bioPmed smart approach”
(Converging technologies)
- Up to 250 companies working specifically in
health care
- Over xx.000 companies working in ICT,
Mechatronics, New Materials, textiles, etc
80+ bioPmed cluster CORE MEMBERS
share the approach of a smart Healthcare cluster aiming at
“Overlapping different technological knowledge to reach innovative
solutions to
unmet medical needs and ensure a better future”
THE BIOPMED SMART APPROACH

13. / 13Bioindustry Park 2013– All Rights Reserved
BIOENGINEERING
BIOLOGY
ENGINEERING
COMPUTER
SCIENCE
NANOTECHNOLOGY
BIOLOGY
ENGINEERING
CHEMISTRY
PHYSICS
COMPUTER
SCIENCE
BIO MECHATRONICS
MECHANICAL
ENGINEERING
ELECTRICAL
ENGINEERING
COMPUTER
SCIENCE
PERVASIVE COMPUTING
This includes
engineering, computer
science and all of the
liberal arts
MATERIAL SCIENCE
MATERIAL
ENGINEERIN
G
CHEMISTRY
PHYSICS
* Source: Proceedings of the 2002 American Society for Engineering Education Annual Conference & Exposition
Copyright 2002, American Society for Engineering Education
BIOLOGY
BASED ON CONVERGING TECHNOLOGIES

14. / 14Bioindustry Park 2013– All Rights Reserved
AND A STRATEGIC PERSPECTIVE
• While the current, almost “traditional”, concept of Personalised
Medicine stands for the customisation of healthcare for patient
subgroups through medical decisions, practices and products,
the future will be probably the development of a Personalised
Healthcare with a solution-driven approach, bringing together
the necessary industry sectors.
• This shall not only involve therapeutics and diagnostics research
& development, but also include other technological
approaches for the lifelong management of health and
healthcare, like e-Health (patient care using IT solutions and
devices), medical technologies, new materials, electronics and
mechatronics, but also the involvement of “traditional” low-
medium tech sectors such as agro-food, cosmetics and textiles.

15. / 15Bioindustry Park 2013– All Rights Reserved
WORKING ON LINKS BETWEEN DIFFERENT TECHNOLOGICAL &
MARKET FIELDS
Therapy Diagnostic Med-tech CosmeticHealth systems Food
Personalised medicine
Personalised health care approach
Key Enabling Technologies (KET) and Future Emerging Technologies (FET)
R&D, Industry, PAs, Users
T
e
c
h
n
o
l
o
g
i
e
s

16. / 16Bioindustry Park 2013– All Rights Reserved
To develop a common and joint internationalisation strategy for the
4 Life Sciences Clusters, in order to reinforce the European SMEs’
competitiveness outside Europe
Mutualising and sharing internationalisation tools (programs,
practices, networks) already implemented to obtain economy of
scale/knowledge
Identifying the most efficient tools for SMEs’ competitiveness on the
global market
Testing common pilot actions towards 3 targeted markets: Brazil,
China, United States
Reinforcing the visibility of the 4 European Life Sciences Clusters
together and European competences worldwide
ERAI (Rhône-Alpes, FR)
Project Leader
Lyonbiopole (Rhône-Alpes, FR)
Host Cluster
BioCat (Catalonia, SP)
Invited Cluster
BioM (Bayern Region, DE)
Invited Cluster
BioPmed (Piedmont, IT)
Invited Cluster
www.bioxcluster.com
AN INTERNATIONAL PLATFORM BASED ON A SHARED VISION

17. / 17Bioindustry Park 2013– All Rights Reserved
A POSSIBLE FURTHER STEP: A STRATEGIC CLUSTER
PARTNERSHIP FOR PERSONALIZED MEDICINE
bioXclusters as the common starting platform to involve
other European health clusters to develop a strong
European Alliance on Personalised Healthcare
The Strategic Cluster Partnership (ESCP) initiative with a focus on
Personalised Healthcare
 5 different market-oriented clusters (bioPmed, Lyonbiopole,
BioM, BioCat and Health Science Scotland, 3 with quality
assessed ESCA Bronze label, 4 involved in a world class cluster
project, bioXclusters)
 A common strategic agenda based on an intersectorial
converging technologies approach
 First step of evaluation already passed
A global vision:
Today
US
China
Brazil
and in the future…
Korea
Japan
North Africa

18. / 18Bioindustry Park 2013– All Rights Reserved
 The health care paradigm is changing:
 Cost factor
 Technology advancements
 Societal needs
 bioPmed is leveraging on all available technologies in order to
develop - through R&D projects - solutions to such challenges
 bioPmed is using the power of partnership to work together
with key clusters in Europe to create a pan European platform -
based on a personalised healthcare vision - that could act as a
real global actor.
TAKE AWAY MESSAGES

19. / 19Bioindustry Park 2013– All Rights Reserved
Try to think big and on the long term
Life Long health management should be
the paradigm
Work on the integration of healthcare
systems at European Level
TOP 3 RECOMMENDATIONS FOR ACHIEVING TANGIBLE RESULTS

20. / 20Bioindustry Park 2013– All Rights Reserved
A solution-oriented approach, based on the
integration of multiple technological
domains
An international vision and development
strategy based on partnerships and
complementarities
WHAT CAN WE OFFER

21. / 21Bioindustry Park 2013– All Rights Reserved
Partners sharing our vision and approach
Ready to work on a global scale
WHAT ARE WE LOOKING FOR

22. / 22Bioindustry Park 2013– All Rights Reserved
BIO-Europe Spring®
will be organised
in Turin (Piemonte)
March 10–12, 2014
http://www.ebdgroup.com/bes/program/index.php
BIO-EUROPE SPRING® 2014

23. Bioindustry Park Silvano Fumero S.p.A.
Alberto Baldi
DBusiness Development and International projects
baldi@bioindustrypark.it
Via Ribes, 5
10010 Colleretto Giacosa (TO)
ITALY
Tel. +39-0125-561311
info@biopmed.eu
www.biopmed.eu
www.bioindustrypark.euIt is the team that wins
not the single player…..